951 related articles for article (PubMed ID: 1944470)
1. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
2. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
[TBL] [Abstract][Full Text] [Related]
3. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
[TBL] [Abstract][Full Text] [Related]
4. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1.
Corbet A; Bucciarelli R; Goldman S; Mammel M; Wold D; Long W
J Pediatr; 1991 Feb; 118(2):277-84. PubMed ID: 1993961
[TBL] [Abstract][Full Text] [Related]
5. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
Stevenson D; Walther F; Long W; Sell M; Pauly T; Gong A; Easa D; Pramanik A; LeBlanc M; Anday E
J Pediatr; 1992 Feb; 120(2 Pt 2):S3-12. PubMed ID: 1735849
[TBL] [Abstract][Full Text] [Related]
6. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, randomized, placebo-controlled Canadian multicenter trial of two doses of synthetic surfactant or air placebo in 224 infants weighing 500 to 749 grams with respiratory distress syndrome. Canadian Exosurf Neonatal Study Group.
Smyth J; Allen A; MacMurray B; Peliowski A; Sankaran K; Volberg F; Shukla A; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S81-9. PubMed ID: 7745516
[TBL] [Abstract][Full Text] [Related]
8. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
[TBL] [Abstract][Full Text] [Related]
9. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
10. Inositol supplementation in premature infants with respiratory distress syndrome.
Hallman M; Bry K; Hoppu K; Lappi M; Pohjavuori M
N Engl J Med; 1992 May; 326(19):1233-9. PubMed ID: 1560798
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
[TBL] [Abstract][Full Text] [Related]
12. Effects of two rescue doses of synthetic surfactant in 344 infants with respiratory distress syndrome weighing 750 to 1249 grams: a double-blind, placebo-controlled multicenter Canadian trial. Canadian Exosurf Neonatal Study Group.
McMillan D; Chernick V; Finer N; Schiff D; Bard H; Watts J; Krzeski R; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S90-8. PubMed ID: 7745517
[TBL] [Abstract][Full Text] [Related]
13. Surfactant therapy in respiratory distress syndrome--the first local experience.
Lim NL; Nordin MM; Cheah IG
Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989
[TBL] [Abstract][Full Text] [Related]
14. Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant.
Corbet AJ; Long WA; Murphy DJ; Garcia-Prats JA; Lombardy LR; Wold DE
J Paediatr Child Health; 1991 Aug; 27(4):245-9. PubMed ID: 1958425
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study.
Garland J; Buck R; Weinberg M
Pediatrics; 1994 Nov; 94(5):719-23. PubMed ID: 7936902
[TBL] [Abstract][Full Text] [Related]
16. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.
Laughon M; Bose C; Moya F; Aschner J; Donn SM; Morabito C; Cummings JJ; Segal R; Guardia C; Liu G;
Pediatrics; 2009 Jan; 123(1):89-96. PubMed ID: 19117865
[TBL] [Abstract][Full Text] [Related]
17. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.
Bose C; Corbet A; Bose G; Garcia-Prats J; Lombardy L; Wold D; Donlon D; Long W
J Pediatr; 1990 Dec; 117(6):947-53. PubMed ID: 2246698
[TBL] [Abstract][Full Text] [Related]
18. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group.
Anzueto A; Baughman RP; Guntupalli KK; Weg JG; Wiedemann HP; Raventós AA; Lemaire F; Long W; Zaccardelli DS; Pattishall EN
N Engl J Med; 1996 May; 334(22):1417-21. PubMed ID: 8618579
[TBL] [Abstract][Full Text] [Related]
19. Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.
Phibbs RH; Ballard RA; Clements JA; Heilbron DC; Phibbs CS; Schlueter MA; Sniderman SH; Tooley WH; Wakeley A
Pediatrics; 1991 Jul; 88(1):1-9. PubMed ID: 2057244
[TBL] [Abstract][Full Text] [Related]
20. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome.
Hoekstra RE; Jackson JC; Myers TF; Frantz ID; Stern ME; Powers WF; Maurer M; Raye JR; Carrier ST; Gunkel JH
Pediatrics; 1991 Jul; 88(1):10-8. PubMed ID: 2057245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
